Scilex Holding Company Stock Issued During Period, Shares, Issued for Services
Scilex Holding Company (SCLX) had Stock Issued During Period, Shares, Issued for Services of 285.71 thousand shares as of 2024-07-01, per its 10-Q filed 2026-08-14.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2026-08-14
- 2024-07-01: Stock Issued During Period, Shares, Issued for Services 285.71K shares; Stock Issued During Period, Shares, Issued for Services as first filed 10.00M shares.
- 2023-07-01: Stock Issued During Period, Shares, Issued for Services 10.00M shares.
- 2023-02-13: Stock Issued During Period, Shares, Issued for Services 114.29K shares; Stock Issued During Period, Shares, Issued for Services as first filed 4.00M shares.
| Period end | Stock Issued During Period, Shares, Issued for Services | Stock Issued During Period, Shares, Issued for Services as first filed |
|---|---|---|
| 2024-07-01 | 285.71K shares 10-Q · filed 2026-08-14 | 10.00M shares 10-Q · filed 2024-08-13 |
| 2023-07-01 | 10.00M shares 10-K · filed 2025-03-31 | |
| 2023-02-13 | 114.29K shares 10-Q · filed 2026-08-14 | 4.00M shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |